Skip to main content
Publications
Law EH, Galve-Calvo E, Wockel A, Parikh R, Kurosky SK, Derrien Ansquer V, Frugier G, Davis KL, Esterberg E, Oikonomidou O. European treatment patterns and outcomes associated with first-line CDK4/6 inhibition and hormonal therapies assessed in a real-world non-interventional study (EUCHARIS). Poster presented at the 2021 San Antonio Breast Cancer Symposium (SABCS); December 7, 2021. San Antonio, TX. [abstract] Cancer Res. 2022 Feb 15; 82(4_Suppl):OT2-19-04. doi: 10.1158/1538-7445.SABCS21-OT2-19-04
Elmasry MA, Sampani K, Abdelal OM, Fleming A, Souka A, Elbaha S, Silva PS, Sun JK, Aiello LP. Disparity of microaneurysm count between ultrawide field color imaging (UWF-CI) and ultrawide field fluorescein angiography (UWF-FA) in eyes with diabetic retinopathy. Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun; 61(7):5306.
Silva PS, Cavallerano J, Elmasry MA, Fleming A, van Hemert J, Lewis D, Bhaskar V, Tolson A, Tolls D, Sun JK, Aiello LP. Impact of visible retinal area on diabetic retinopathy severity and detection of predominantly peripheral lesions when using ultrawide field imaging. Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun 1; 61(7):3201.
Shokrollahi S, Elmasry MA, Sampani K, Pisig AU, Abdelal O, Robertson G, Fleming A, Pitoc CM, Sun JK, Silva PS, Aiello LP. Association of ultrawide field (UWF) retinal vessel caliber with diabetic retinopathy (DR) severity, predominantly peripheral lesions (PPL) and retinal nonperfusion (NP). Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4771.
Silva PS, Stanton RC, Elmasry MA, Fleming A, Pellegrini E, van Hemert J, Tolls D, Tolson AM, Lewis D, Stainback J, Cavallerano JD, Sun JK, Aiello LP. Association of systemic comorbities with predominantly peripheral diabetic retinopathy lesions (PPL) identified on ultrawide field (UWF) retinal imaging. Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4772.
Pisig AU, Sampani K, Elmasry MA, Aldairy Y, Robertson G, Fleming A, Pitoc C, Rhee J, Sun JK, Silva PS, Aiello LP. Regional vessel caliber, retinal oximetry and predominantly peripheral diabetic retinal lesions as surrogate markers of nonperfusion on ultrawide field angiography in diabetic eyes. Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):3448.
Sears CM, Hirano T, Nittala MG, Mehta NS, Sinha S, Jayadev C, Singh G, Verhoek M, Fleming A, van Hmert J, Tsui I, Prasad P, Sadda SR. Ethnic variation in diabetic retinopathy lesion distribution. Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):4681.
Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK, Appelbaum PS, Kukafka R, Schechter I, Crew KD. Understanding factors associated with uptake of BRCA genetic testing among Orthodox Jewish women using a mixed-methods approach. Poster presented at the 2017 San Antonio Breast Cancer Symposium; December 2017. San Antonio, TX. [abstract] Cancer Res. 2018 Feb; 78(4 Suppl).
Ali-Shaw T, Ueng WA, Trivedi MS, Yi H, David RR, Vanegas A, Vargas JM, Sandoval R, Wood J, Kukafka R, Crew KD. Adherence to healthy lifestyle behaviors in a predominantly Hispanic population of women undergoing screening mammography. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 2016. San Antonio, TX. [abstract] Cancer Res. 2017 Feb; 77(4_Suppl). doi: 10.1158/1538-7445.SABCS16-P5-10-01
Ueng W, McGuinness J, Infante K, Trivedi MS, Yi HS, David R, Vanegas A, Vargas J, Sandoval R, Kukafka R, Crew KD. Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women. Poster presented at the 107th Annual Meeting of the American Association for Cancer Research; April 2016. New Orleans, LA. [abstract] Cancer Res. 2016 Jul; 76(14_Suppl). doi: 10.1158/1538-7445.AM2016-1790
Archer R, Tappenden P, Ren S, Martyn-St James M, Harvey R, Basarir H, Stevens J, Carroll C, Cantrell A, Lobo A, Hoque S. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technol Assess. 2016 May;20(39):1-326. doi: 10.3310/hta20390
Olson J, Sharp P, Goatman K, Prescott G, Scotland G, Fleming A, Philip S, Santiago C, Borooah S, Broadbent D, Chong V, Dodson P, Harding S, Leese G, Styles C, Swa K, Wharton H. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013 Nov 1;17(51):1-142. doi: 10.3310/hta17510
Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Den Berg DV, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Kjaer SK, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah HDP, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res. 2009 Mar;69(6):2349-57.